comparemela.com
6
7
8
9
10
11
12
Latest Breaking News On - Genitourinary cancers - Page 5 : comparemela.com
More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects
More fatigue, depression, worse reaction time with enzalutamide as compared with abiraterone
New-york
United-states
Steven-vogl
Amit-bahl
Charles-bankhead
University-hospitals-bristol
Genitourinary-cancers
New-york-city
Medpage-today
First-Line Combo for Cisplatin-Ineligible Bladder Cancer Just Misses Positive Result
Cabozantinib-pembrolizumab induced responses in 16 of 35 evaluable patients, but needed one more
Phoenix
Arizona
United-states
Florida
Tampa
Charles-bankhead
Rohitk-jain
Parminder-singh
Moffitt-cancer-center
Genitourinary-cancers
Mayo-clinic
Medpage-today
Another Prostate Cancer Screening Candidate Outperforms Standard PSA Testing
Multiparametric Stockholm3 avoided far more unnecessary biopsies without sacrificing sensitivity
Stockholm
Sweden
Canada
United-states
American
Scott-eggener
Prostate-health-index
University-of-chicago
Genitourinary-cancers
Prostate-health
North-american
African-american
Adjuvant Pembrolizumab Boosts DFS in High-Risk Muscle Invasive Urothelial Cancer
Benefit more than double with the immune checkpoint inhibitor compared with observation
Memorial-sloan-kettering-cancer-center
New-york
United-states
Bethesda
Maryland
Jonathan-rosenberg
National-cancer-institute-in-bethesda
Cancer-research
National-cancer-institute
Genitourinary-cancers
New-york-city
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC
Combination improved PFS versus more hormonal therapy, but control arm questioned
Massachusetts
United-states
United-kingdom
Vancouver
British-columbia
Canada
Salt-lake-city
Utah
University-of-utah
British
Mike-bassett
Neeraj-agarwal
vimarsana © 2020. All Rights Reserved.